Where these figures come from
The SEC’s companyfacts data: the full-year figures Haemonetics tagged in XBRL in its annual reports (10-K, 20-F or 40-F). When a later report restates a year, the later figure is used. Revenue, cost of revenue, gross profit, research and development, selling, general and administrative costs, operating income, pre-tax income, income tax and net income are the company’s own lines.
Lines marked * are differences: other operating costs are gross profit minus operating profit minus the cost lines the company tagged; “interest and other” is operating profit minus tax minus net income, so it holds interest, investment gains and losses, minority stakes and discontinued operations together. When the tagged cost of revenue and gross profit disagree, the company’s gross profit is kept. The segment, product and region splits come from the dimensioned revenue facts of the latest annual report’s XBRL instance: a split is shown only when its parts add up to the company’s total revenue within 1%, and labels are the company’s own. This page describes the past and is not investment advice. No language model wrote it.